0120G0.KO Samyang Biopharm

Healthcare Medical Devices Korea Stock Exchange
39,700 KRW
Close of Nov 5, 2026
23,250 150,900
Market cap
KRW 295B
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is 0120G0.KO undervalued?

Graham number

The Graham number of Samyang Biopharm cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Samyang Biopharm fundamental analysis

No fundamental analysis for Samyang Biopharm yet.

Samyang Biopharm stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Samyang Biopharm

Samyang Biopharm Corporation offers pharmaceutical and biotech products. The company was founded in 2011 and is based in Seoul, South Korea.

Full company profile